These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2577048)

  • 1. Effects of D1 and D2 dopamine antagonists on heroin-trained drug discrimination.
    Corrigall WA; Coen KM
    NIDA Res Monogr; 1989; 95():499. PubMed ID: 2577048
    [No Abstract]   [Full Text] [Related]  

  • 2. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of D1-like and D2-like dopamine receptors in the brain of genetic epileptic WAG/Rij rats.
    Birioukova LM; Midzyanovskaya IS; Lensu S; Tuomisto L; van Luijtelaar G
    Epilepsy Res; 2005 Feb; 63(2-3):89-96. PubMed ID: 15715998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective D1 and D2 dopamine antagonists decrease response rates of food-maintained behavior and reduce the discriminative stimulus produced by heroin.
    Corrigall WA; Coen KM
    Pharmacol Biochem Behav; 1990 Feb; 35(2):351-5. PubMed ID: 2181485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeons.
    Gargiulo PA; Acerbo MJ; Krug I; Delius JD
    Pharmacol Biochem Behav; 2005 Aug; 81(4):732-9. PubMed ID: 15979133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Psychopharmacol Bull; 1986; 22(3):605-12. PubMed ID: 2879304
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.
    Koob GF; Le HT; Creese I
    Neurosci Lett; 1987 Aug; 79(3):315-20. PubMed ID: 2958724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine.
    Hu JY; Jin GZ
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):715-9. PubMed ID: 10678104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of avoidance responding by amphetamine and dopamine receptor antagonists.
    Jakubowska-Doğru E
    Pol J Pharmacol; 1999; 51(4):301-9. PubMed ID: 10540961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1123-36. PubMed ID: 9618415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen increases the sensitivity of ovariectomized rats to the disruptive effects produced by antagonism of D2 but not D1 dopamine receptors during performance of a response learning task.
    Daniel JM; Sulzer JK; Hulst JL
    Horm Behav; 2006 Jan; 49(1):38-44. PubMed ID: 15936760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.